News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts

Spotlight -

Downstream Processing|

Upstream Processing

Wendy Porter

Articles by Wendy Porter

The CRO Advantage: Outsource Clinical Trials to Launch Biotech Development Success

BySusan Krivacic,Wendy Porter

June 1st 2005

Less than 35 percent of all biotech companies have sufficient finances to survive beyond one year.

Latest Updated Articles

The CRO Advantage: Outsource Clinical Trials to Launch Biotech Development Success
Published: June 1st 2005 | Updated:

Trending on BioPharm International

In-Vivo Cell Therapy Model Aims to Reduce Manufacturing Challenges

Can New Funding Models Support Next-Generation Medicines?

© 2025 MJH Life Sciences^®

All rights reserved.